Biofortis, Merieux NutriSciences
9
1
1
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 9 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
Dihydroberberine Effects on Body Composition and Metabolic Health in Healthy Adults
Role: collaborator
Effects of Dihydroberberine (DHB) on GLP-1, Glycemic Control, Appetite, and Mood in Adults With Pre-Diabetes
Role: collaborator
A Nutritional Supplement on Vasomotor Symptoms in Women
Role: collaborator
Clinical Trial to Evaluate the Efficacy and Safety of the Probiotic Strains Limosilactocillus Reuteri DSM 32910 and Lacticaseibacillus Paracasei DSM 32851 on Glucose Homeostatis in Prediabetic Adults
Role: collaborator
Safety of an Infant Formula With Hydrolysed Protein in Term Infants
Role: collaborator
Phytochemicals on "Metabolic Aging" in Older Overweight Adults
Role: lead
Effect of an Arabinogalactan Product
Role: lead
To Investigate the Effect of Arabinogalactan on the Gut Microbiome in Adults
Role: lead
A Double Blind Study on the Gastrointestinal Effects of Arabinoxylan (Leaf Fiber Extract).
Role: collaborator
All 9 trials loaded